Trial Search Results
Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection
To compare the positivity rate of the investigational assay to the currently approved QuantiFERON-TB Gold In-Tube assay.
Stanford is currently not accepting patients for this trial.
QIAGEN Gaithersburg, Inc
- Device: CST001
Low Risk and Known Risk Cohorts
- Compensated and uncompensated members (current or future) of the Department of
Veterans Affairs with no identified symptoms of active TB disease
- Age greater than 18 years or less than 80 years.
- Currently taking therapy for active tuberculosis or latent TB infection for more than
Ages Eligible for Study
18 Years - 80 Years
Genders Eligible for Study